Evidence map›Paper›PMID 25471062›Full record

Trial reportBMC psychiatry2014

Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study.

Vinod H Srihari, Cenk Tek, Jessica Pollard, Suzannah Zimmet, Jane Keat, John D Cahill, Suat Kucukgoncu, Barbara C Walsh, Fangyong Li, Ralitza Gueorguieva and 7 more

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02069925 (STEP-ED), which is not on this map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02069925 nacompletednot on this map

STEP-ED: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.

TypeinterventionalSponsorYale UniversityRan2014 to 2020Enrolled285ConditionsPsychosis, SchizophreniaArmsEarly Detection (ED), Usual Detection
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Vinod H SrihariDepartment of Psychiatry, Yale University, 34 Park Street, New Haven, CT, 06519, USA. vinod.srihari@yale.edu.
Cenk TekDepartment of Psychiatry, Yale University, 34 Park Street, New Haven, CT, 06519, USA. cenk.tek@yale.edu.
Jessica PollardDepartment of Psychiatry, Yale University, 34 Park Street, New Haven, CT, 06519, USA. Jessica.pollard@yale.edu.
Suzannah ZimmetCommonwealth Research Center, Massachusetts Mental Health Center Division of Public Psychiatry, Beth Israel Deaconess Medical Center, Department of Psychiatry, Harvard Medical School, 75 Fenwood Road, 5th Floor, Boston, MA, 02115, USA. szimmet@bidmc.harvard.edu.
Jane KeatDepartment of Psychiatry, Yale University, 34 Park Street, New Haven, CT, 06519, USA. jekeat@gmail.com.
John D CahillDepartment of Psychiatry, Yale University, 34 Park Street, New Haven, CT, 06519, USA. john.cahill@yale.edu.
Suat KucukgoncuDepartment of Psychiatry, Yale University, 34 Park Street, New Haven, CT, 06519, USA. suat.kucukgoncu@yale.edu.
Barbara C WalshDepartment of Psychiatry, Yale University, 34 Park Street, New Haven, CT, 06519, USA. barbara.walsh@yale.edu.
Fangyong LiYale Center for Analytical Sciences (YCAS), 300 George Street, New Haven, CT, 06511, USA. fang-yong.li@yale.edu.
Ralitza GueorguievaYale Center for Analytical Sciences (YCAS), 300 George Street, New Haven, CT, 06511, USA. ralitza.gueorguieva@yale.edu.
Nina LevineDepartment of Psychiatry, Yale University, 34 Park Street, New Haven, CT, 06519, USA. nina.levine@yale.edu.
Raquelle I Mesholam-GatelyCommonwealth Research Center, Massachusetts Mental Health Center Division of Public Psychiatry, Beth Israel Deaconess Medical Center, Department of Psychiatry, Harvard Medical School, 75 Fenwood Road, 5th Floor, Boston, MA, 02115, USA. rmeshola@bidmc.harvard.edu.
Michelle Friedman-YakoobianCommonwealth Research Center, Massachusetts Mental Health Center Division of Public Psychiatry, Beth Israel Deaconess Medical Center, Department of Psychiatry, Harvard Medical School, 75 Fenwood Road, 5th Floor, Boston, MA, 02115, USA. mfriedm3@bidmc.harvard.edu.
Larry J SeidmanCommonwealth Research Center, Massachusetts Mental Health Center Division of Public Psychiatry, Beth Israel Deaconess Medical Center, Department of Psychiatry, Harvard Medical School, 75 Fenwood Road, 5th Floor, Boston, MA, 02115, USA. lseidman@bidmc.harvard.edu.
Matcheri S KeshavanCommonwealth Research Center, Massachusetts Mental Health Center Division of Public Psychiatry, Beth Israel Deaconess Medical Center, Department of Psychiatry, Harvard Medical School, 75 Fenwood Road, 5th Floor, Boston, MA, 02115, USA. mkeshava@bidmc.harvard.edu.
Thomas H McGlashanDepartment of Psychiatry, Yale University, 34 Park Street, New Haven, CT, 06519, USA. thomas.mcglashan@yale.edu.
Scott W WoodsDepartment of Psychiatry, Yale University, 34 Park Street, New Haven, CT, 06519, USA. scott.woods@yale.edu.
Yale University · USBeth Israel Deaconess Medical Center · USYale Cancer Center · US

Funding

Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
STEP-ED:Reducing Duration of Untreated Psychosis and its Impact in the U.S.R01MH103831 · NIMH · YALE UNIVERSITY · PI SRIHARI, VINOD H. · 2013 to 2017
$3.9M
NCATS NIH HHS UL1 TR000142NIMH NIH HHS 1R01MH103831-01NIMH NIH HHS R01 MH103831
6 · The paper itself

Abstract

backgroundEarly intervention services for psychotic disorders optimally interlock strategies to deliver: (i) Early Detection (ED) to shorten the time between onset of psychotic symptoms and effective treatment (i.e. Duration of Untreated Psychosis, DUP); and (ii) comprehensive intervention during the subsequent 2 to 5 years. In the latter category, are teams ('First-episode Services' or FES) that integrate several empirically supported treatments and adapt their delivery to younger patients and caregivers. There is an urgent need to hasten access to established FES in the U.S. Despite improved outcomes for those in treatment, these FES routinely engage patients a year or more after psychosis onset. The Scandinavian TIPS study was able to effectively reduce DUP in a defined geographic catchment. The guiding questions for this study are: can a U.S. adaptation of the TIPS approach to ED substantially reduce DUP and improve outcomes beyond existing FES? METHODS/

designThe primary aim is to determine whether ED can reduce DUP in the US, as compared to usual detection. ED will be implemented by one FES (STEP) based in southern Connecticut, and usual detection efforts will continue at a comparable FES (PREP(R)) serving the greater Boston metropolitan area. The secondary aim is to determine whether DUP reduction can improve presentation, engagement and early outcomes in FES care. A quasi-experimental design will compare the impact of ED on DUP at STEP compared to PREP(R) over 3 successive campaign years. The campaign will deploy 3 components that seek to transform pathways to care in 8 towns surrounding STEP. Social marketing approaches will inform a public education campaign to enable rapid and effective help-seeking behavior. Professional outreach and detailing to a wide variety of care providers, including those in the healthcare, educational and judicial sectors, will facilitate rapid redirection of appropriate patients to STEP. Finally, performance improvement measures within STEP will hasten engagement upon referral. DISCUSSION: STEP-ED will test an ED campaign adapted to heterogeneous U.S. pathways to care while also improving our understanding of these pathways and their impact on early outcomes.

trial registrationClinicalTrials.gov: NCT02069925 . Registered 20 February 2014.

Indexed as

Delivery of Health CareEarly DiagnosisHealth Services Needs and DemandHumansPsychotic DisordersTime FactorsTreatment OutcomeUnited States

Identifiers

PMID25471062
PMCPMC4262386
OpenAlexW2125764655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.